Since HEVs are entrance portals for lymphocytes, intratumoral HEVs in conjunction with normalized blood vessels in cancer are highly significant for immunotherapy, in particular, for ‘cold’ tumours which lack effector T cell infiltration ( 45 , 46 ).
1
—
—